What is the difference between U500 (500 units per milliliter) insulin and U100 (100 units per milliliter) insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

U-500 vs U-100 Insulin: Key Differences

U-500 insulin is five times more concentrated than U-100 insulin (500 units/mL vs 100 units/mL), but the critical difference is that U-500 regular insulin has fundamentally different pharmacokinetics—it acts more like an intermediate-acting (NPH) insulin with delayed, blunted peak and prolonged duration, rather than like standard regular insulin. 1, 2

Concentration Differences

  • U-100 insulin: 100 units per milliliter (standard concentration)
  • U-500 insulin: 500 units per milliliter (5× more concentrated)

This means you inject 1/5th the volume to deliver the same number of units 3, 4.

Pharmacokinetic Differences (The Most Important Distinction)

U-500 regular insulin does NOT behave like U-100 regular insulin despite both being "regular" insulin:

  • Similar onset but delayed, blunted, and prolonged peak effect
  • Longer duration of action (18-21 hours vs typical regular insulin)
  • Characteristics resemble a premixed intermediate-acting (NPH) and regular insulin product 1, 2
  • Can be dosed as 2-3 times daily (not meal-by-meal like typical regular insulin) 1

In contrast, other concentrated insulins (U-200 degludec, U-200 lispro, U-300 glargine) have pharmacokinetics similar to their U-100 counterparts, with U-300 glargine being the exception showing modestly lower efficacy per unit 1.

Clinical Indications

U-500 insulin is specifically indicated for patients with type 2 diabetes requiring >200 units of insulin daily due to severe insulin resistance 5, 6. The concentrated formulation allows:

  • Reduced injection volume (less painful, better absorption than large-volume U-100 injections)
  • Fewer daily injections (2-3 times daily vs multiple injections)
  • Improved adherence in insulin-resistant patients 1, 5

U-100 insulins remain standard for most patients with lower insulin requirements.

Safety Considerations: Critical Dosing Errors

U-500 insulin carries significant risk of dosing errors that can cause severe hypoglycemia or hyperglycemia:

  • Available in both prefilled pens AND vials (unlike other concentrated insulins which are pen-only to minimize errors) 1, 2
  • If U-500 vials are prescribed, MUST prescribe U-500-specific syringes to prevent catastrophic dosing errors 1, 2
  • Never use U-100 syringes with U-500 insulin—this would deliver 5× the intended dose

Other concentrated insulins (U-200, U-300) are available only in prefilled pens specifically to minimize dosing errors 1.

Practical Prescribing Algorithm

For patients requiring >200 units insulin daily:

  1. Calculate total daily insulin requirement
  2. Convert to U-500 dosing (same number of units, but 1/5th the volume)
  3. Prescribe as 2-3 times daily regimen (not meal-by-meal)
  4. If using vials: Must prescribe U-500 syringes simultaneously
  5. If using pens: Prefilled U-500 pens available

For patients requiring <200 units daily:

  • Continue U-100 insulins (rapid-acting, long-acting, or premixed as clinically appropriate)

Cost Considerations

Per 1,000 units, U-500 insulin costs are comparable to U-100 regular insulin:

  • U-500 vial: $178 (AWP), $142 (NADAC)
  • U-500 pen: $230 (AWP), $184 (NADAC)
  • U-100 regular vial: $172 (AWP), $137 (NADAC) 1

The advantage is convenience and reduced injection volume, not necessarily cost savings.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.